Erectile dysfunction among patients and health care providers during COVID-19 pandemic: A systematic review

Int J Impot Res. 2022 Mar;34(2):145-151. doi: 10.1038/s41443-021-00504-w. Epub 2022 Jan 7.

Abstract

COVID-19 pandemic is associated with devastating effects on social, psychological, and economical aspects of survivors. We assume that erectile function (EF) is affected as well. We performed a systematic review of the published articles about the change in EF among patients and health care providers during the COVID-19 pandemic. We searched PubMed and Cochrane databases for English literature using a combination of medical subject headings (MeSH) terms and keywords. We extracted data of erectile dysfunction (ED) rate, international index of erectile function (IIEF), changes related to exposure to the pandemic (Primary objectives), and factors affecting these differences (Secondary objectives). Twenty articles were included in the screening phase. Only 3 articles were eligible for primary objectives, and 2 articles were included for the secondary objective. Three articles revealed an increase in ED cases and a reduction in IIEF-5 scores during the pandemic. Rates of ED have ranged from 32% to 87% of the study populations. Anxiety, depression, and post-traumatic stress disorder (PTSD) were associated with increased ED rates. We conclude that the COVID-19 pandemic is associated with increased rates of ED. Anxiety and depression augment this increase. Health care providers are at higher risk for PTSD, which increases the risk of ED.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • COVID-19* / epidemiology
  • Erectile Dysfunction* / diagnosis
  • Erectile Dysfunction* / epidemiology
  • Erectile Dysfunction* / etiology
  • Health Personnel
  • Humans
  • Male
  • Pandemics
  • Penile Erection